Fragment-based drug discovery (FBDD) has proven to be a successful approach for the identification of hit molecules, which can be optimised to improve potency and properties in hit-to-lead campaigns.
This infographic offers a timeline of key discoveries that have advanced FBDD, reviews the clinical pipeline, considers key principles of library design, and presents notable case studies in growing, merging, and linking fragments to achieve specificity and potency.
